ArticleCureus2025
CT-Guided Percutaneous Cryoablation of a Renal Metastasis From Esophageal Adenocarcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal involvement in esophageal adenocarcinoma is an uncommon clinical finding. We describe the case of a 74-year-old man with stage IV esophageal adenocarcinoma and prior hepatic, retroperitoneal nodal, and cerebral metastases who developed a new hypermetabolic lesion in the left kidney on Positron Emission Tomography/Computed Tomography (PET/CT). MRI identified a 3.4 cm enhancing mass, and biopsy confirmed poorly differentiated metastatic adenocarcinoma. The lesion was treated with CT-guided cryoablation using a dual freeze-thaw protocol. The patient tolerated the procedure well, and a small upper-pole bleed identified immediately post-procedure was successfully managed with selective coil embolization. He resumed systemic therapy and remained asymptomatic at the four-week follow-up, with a complete metabolic response at the ablation site on the follow-up PET/CT. This case illustrates the feasibility of CT-guided percutaneous cryoablation as a minimally invasive option for local control of renal metastases in patients with esophageal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.